Fischer Stefan

Insider CIK 1398596 · ACER 10% owner · ENTA 10% owner · BLUE 10% owner · PRTO 10% owner · CNCE 10% owner

Track record PRO

XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%

Track record

See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.

Upgrade to Pro · $99/year Already Pro? Log in

Trades across companies

Ticker	Code	Trade	Filed	Shares	Price	Value	Owned after
ACER Acer Therapeutics Inc.	P Buy	2018-08-01	2018-08-22	275,000	$18.00	$4.95M	1,697,709	SEC↗
ACER Acer Therapeutics Inc.	P Buy	2017-12-12	2018-01-12	21,271	$12.00	$255.3K	248,756	SEC↗
ACER Acer Therapeutics Inc.	P Buy	2017-12-12	2018-01-12	250,000	$12.00	$3.00M	1,422,709	SEC↗
ACER Acer Therapeutics Inc.	P Buy	2017-12-12	2018-01-12	62,062	$12.00	$744.7K	725,844	SEC↗
ACER Acer Therapeutics Inc.	J Other	2017-09-19	2017-09-27	227,485	—	$0	227,485	SEC↗
ACER Acer Therapeutics Inc.	J Other	2017-09-19	2017-09-27	1,172,709	—	$0	1,172,709	SEC↗
ACER Acer Therapeutics Inc.	J Other	2017-09-19	2017-09-27	663,782	—	$0	663,782	SEC↗
PRTO PROTEON THERAPEUTICS INC	P Buy deriv	2017-06-22	2017-06-26	128	$1000.00	$128.0K	500	SEC↗
PRTO PROTEON THERAPEUTICS INC	P Buy deriv	2017-06-22	2017-06-26	372	$1000.00	$372.0K	500	SEC↗
PRTO PROTEON THERAPEUTICS INC	P Buy deriv	2017-06-22	2017-06-30	372	$1000.00	$372.0K	500	SEC↗
PRTO PROTEON THERAPEUTICS INC	C Conversion deriv	2014-10-27	2014-10-30	799,043	—	$0	0	SEC↗
PRTO PROTEON THERAPEUTICS INC	C Conversion deriv	2014-10-27	2014-10-30	1,531,518	—	$0	0	SEC↗
PRTO PROTEON THERAPEUTICS INC	C Conversion deriv	2014-10-27	2014-10-30	2,092,735	—	$0	0	SEC↗
PRTO PROTEON THERAPEUTICS INC	C Conversion deriv	2014-10-27	2014-10-30	717,260	—	$0	0	SEC↗
PRTO PROTEON THERAPEUTICS INC	C Conversion deriv	2014-10-27	2014-10-30	2,436,618	—	$0	0	SEC↗
PRTO PROTEON THERAPEUTICS INC	C Conversion deriv	2014-10-27	2014-10-30	835,121	—	$0	0	SEC↗
PRTO PROTEON THERAPEUTICS INC	C Conversion deriv	2014-10-27	2014-10-30	2,331,391	—	$0	0	SEC↗
PRTO PROTEON THERAPEUTICS INC	J Other deriv	2014-10-27	2014-10-30	451,276	—	$0	0	SEC↗
PRTO PROTEON THERAPEUTICS INC	C Conversion deriv	2014-10-27	2014-10-30	3,727,823	—	$0	0	SEC↗
PRTO PROTEON THERAPEUTICS INC	C Conversion deriv	2014-10-27	2014-10-30	1,277,663	—	$0	0	SEC↗
PRTO PROTEON THERAPEUTICS INC	X Exercise deriv	2014-10-27	2014-10-30	116,511	—	$0	0	SEC↗
PRTO PROTEON THERAPEUTICS INC	X Exercise deriv	2014-10-27	2014-10-30	39,932	—	$0	0	SEC↗
PRTO PROTEON THERAPEUTICS INC	J Other deriv	2014-10-27	2014-10-30	1,316,683	—	$0	0	SEC↗
PRTO PROTEON THERAPEUTICS INC	C Conversion deriv	2014-10-27	2014-10-30	4,468,482	—	$0	0	SEC↗
PRTO PROTEON THERAPEUTICS INC	X Exercise	2014-10-27	2014-10-30	39,932	$4.60	$183.7K	1,943,059	SEC↗
PRTO PROTEON THERAPEUTICS INC	X Exercise	2014-10-27	2014-10-30	116,511	$4.60	$536.0K	1,903,127	SEC↗
PRTO PROTEON THERAPEUTICS INC	C Conversion	2014-10-27	2014-10-30	379,462	—	$0	1,786,616	SEC↗
PRTO PROTEON THERAPEUTICS INC	C Conversion	2014-10-27	2014-10-30	1,107,154	—	$0	1,407,154	SEC↗
PRTO PROTEON THERAPEUTICS INC	P Buy	2014-10-27	2014-10-30	76,590	$10.00	$765.9K	300,000	SEC↗
PRTO PROTEON THERAPEUTICS INC	P Buy	2014-10-27	2014-10-30	223,410	$10.00	$2.23M	223,410	SEC↗
ENTA ENANTA PHARMACEUTICALS INC	S Sale	2014-03-04	2014-03-05	274,880	$38.82	$10.67M	1,178,534	SEC↗
ENTA ENANTA PHARMACEUTICALS INC	S Sale	2014-03-04	2014-03-05	66,506	$38.82	$2.58M	285,129	SEC↗
ENTA ENANTA PHARMACEUTICALS INC	S Sale	2014-03-04	2014-03-05	88,877	$38.82	$3.45M	381,052	SEC↗
ENTA ENANTA PHARMACEUTICALS INC	S Sale	2014-03-04	2014-03-07	88,877	$38.82	$3.45M	370,187	SEC↗
ENTA ENANTA PHARMACEUTICALS INC	S Sale	2014-03-04	2014-03-07	66,506	$38.82	$2.58M	276,999	SEC↗
ENTA ENANTA PHARMACEUTICALS INC	S Sale	2014-03-04	2014-03-07	274,880	$38.82	$10.67M	1,144,932	SEC↗
ENTA ENANTA PHARMACEUTICALS INC	S Sale	2014-03-03	2014-03-05	1,402	$38.83	$54.4K	351,635	SEC↗
ENTA ENANTA PHARMACEUTICALS INC	S Sale	2014-03-03	2014-03-05	1,874	$38.83	$72.8K	469,929	SEC↗
ENTA ENANTA PHARMACEUTICALS INC	S Sale	2014-03-03	2014-03-05	5,795	$38.83	$225.0K	1,453,414	SEC↗
ENTA ENANTA PHARMACEUTICALS INC	S Sale	2014-03-03	2014-03-07	5,795	$38.83	$225.0K	1,419,812	SEC↗
ENTA ENANTA PHARMACEUTICALS INC	S Sale	2014-03-03	2014-03-07	1,874	$38.83	$72.8K	459,064	SEC↗
ENTA ENANTA PHARMACEUTICALS INC	S Sale	2014-03-03	2014-03-07	1,402	$38.83	$54.4K	343,505	SEC↗
ENTA ENANTA PHARMACEUTICALS INC	S Sale	2014-02-26	2014-02-27	11,069	$39.93	$442.0K	471,803	SEC↗
ENTA ENANTA PHARMACEUTICALS INC	S Sale	2014-02-26	2014-02-27	8,283	$39.93	$330.7K	353,037	SEC↗
ENTA ENANTA PHARMACEUTICALS INC	S Sale	2014-02-26	2014-02-27	34,237	$39.93	$1.37M	1,459,209	SEC↗
ENTA ENANTA PHARMACEUTICALS INC	S Sale	2014-02-25	2014-02-27	36,478	$38.92	$1.42M	482,872	SEC↗
ENTA ENANTA PHARMACEUTICALS INC	S Sale	2014-02-25	2014-02-27	27,297	$38.92	$1.06M	361,320	SEC↗
ENTA ENANTA PHARMACEUTICALS INC	S Sale	2014-02-25	2014-02-27	112,826	$38.92	$4.39M	1,493,446	SEC↗
ENTA ENANTA PHARMACEUTICALS INC	S Sale	2014-02-24	2014-02-25	33,602	$39.51	$1.33M	1,572,670	SEC↗
ENTA ENANTA PHARMACEUTICALS INC	S Sale	2014-02-24	2014-02-25	8,130	$39.51	$321.2K	380,487	SEC↗
ENTA ENANTA PHARMACEUTICALS INC	S Sale	2014-02-24	2014-02-25	10,865	$39.51	$429.3K	508,485	SEC↗
ENTA ENANTA PHARMACEUTICALS INC	S Sale	2014-02-21	2014-02-25	1,218	$40.00	$48.7K	388,617	SEC↗
ENTA ENANTA PHARMACEUTICALS INC	S Sale	2014-02-21	2014-02-25	1,628	$40.00	$65.1K	519,350	SEC↗
ENTA ENANTA PHARMACEUTICALS INC	S Sale	2014-02-21	2014-02-25	5,034	$40.00	$201.4K	1,606,272	SEC↗
CNCE CONCERT PHARMACEUTICALS, I	C Conversion deriv	2014-02-19	2014-02-20	841,493	—	$0	0	SEC↗
CNCE CONCERT PHARMACEUTICALS, I	C Conversion deriv	2014-02-19	2014-02-20	1,638,450	—	$0	0	SEC↗
CNCE CONCERT PHARMACEUTICALS, I	C Conversion deriv	2014-02-19	2014-02-20	3,165,187	—	$0	0	SEC↗
CNCE CONCERT PHARMACEUTICALS, I	C Conversion deriv	2014-02-19	2014-02-20	288,407	—	$0	0	SEC↗
CNCE CONCERT PHARMACEUTICALS, I	C Conversion deriv	2014-02-19	2014-02-20	1,084,813	—	$0	0	SEC↗
CNCE CONCERT PHARMACEUTICALS, I	C Conversion deriv	2014-02-19	2014-02-20	561,550	—	$0	0	SEC↗
CNCE CONCERT PHARMACEUTICALS, I	C Conversion	2014-02-19	2014-02-20	148,936	—	$0	1,038,682	SEC↗
CNCE CONCERT PHARMACEUTICALS, I	P Buy	2014-02-19	2014-02-20	22,713	$14.00	$318.0K	378,703	SEC↗
CNCE CONCERT PHARMACEUTICALS, I	P Buy	2014-02-19	2014-02-20	66,287	$14.00	$928.0K	1,104,969	SEC↗
CNCE CONCERT PHARMACEUTICALS, I	C Conversion	2014-02-19	2014-02-20	51,045	—	$0	355,990	SEC↗
CNCE CONCERT PHARMACEUTICALS, I	C Conversion	2014-02-19	2014-02-20	192,003	—	$0	304,945	SEC↗
CNCE CONCERT PHARMACEUTICALS, I	C Conversion	2014-02-19	2014-02-20	99,389	—	$0	112,942	SEC↗
CNCE CONCERT PHARMACEUTICALS, I	C Conversion	2014-02-19	2014-02-20	560,211	—	$0	889,746	SEC↗
CNCE CONCERT PHARMACEUTICALS, I	C Conversion	2014-02-19	2014-02-20	289,991	—	$0	329,535	SEC↗
ENTA ENANTA PHARMACEUTICALS INC	S Sale	2014-02-18	2014-02-20	1,546	$40.19	$62.1K	389,835	SEC↗
ENTA ENANTA PHARMACEUTICALS INC	S Sale	2014-02-18	2014-02-20	6,388	$40.19	$256.7K	1,611,306	SEC↗
ENTA ENANTA PHARMACEUTICALS INC	S Sale	2014-02-18	2014-02-20	2,066	$40.19	$83.0K	520,978	SEC↗
BLUE bluebird bio, Inc.	J Other deriv	2013-06-24	2013-06-24	660,982	—	$0	0	SEC↗
BLUE bluebird bio, Inc.	C Conversion deriv	2013-06-24	2013-06-24	3,010,234	—	$0	0	SEC↗
BLUE bluebird bio, Inc.	C Conversion deriv	2013-06-24	2013-06-24	3,994,248	—	$0	0	SEC↗
BLUE bluebird bio, Inc.	C Conversion deriv	2013-06-24	2013-06-24	17,749,014	—	$0	0	SEC↗
BLUE bluebird bio, Inc.	C Conversion deriv	2013-06-24	2013-06-24	11,835,834	—	$0	0	SEC↗
BLUE bluebird bio, Inc.	C Conversion deriv	2013-06-24	2013-06-24	6,169,117	—	$0	0	SEC↗
BLUE bluebird bio, Inc.	J Other deriv	2013-06-24	2013-06-24	236,062	—	$0	0	SEC↗
BLUE bluebird bio, Inc.	J Other deriv	2013-06-24	2013-06-24	12,445	—	$0	12,445	SEC↗
BLUE bluebird bio, Inc.	J Other deriv	2013-06-24	2013-06-24	236,062	—	$0	0	SEC↗
BLUE bluebird bio, Inc.	J Other deriv	2013-06-24	2013-06-24	12,445	—	$0	12,445	SEC↗
BLUE bluebird bio, Inc.	J Other deriv	2013-06-24	2013-06-24	1,038,674	—	$0	0	SEC↗
BLUE bluebird bio, Inc.	J Other deriv	2013-06-24	2013-06-24	24,393	—	$0	24,393	SEC↗
BLUE bluebird bio, Inc.	J Other deriv	2013-06-24	2013-06-24	287,400	—	$0	0	SEC↗
BLUE bluebird bio, Inc.	J Other deriv	2013-06-24	2013-06-24	34,849	—	$0	34,849	SEC↗
BLUE bluebird bio, Inc.	J Other deriv	2013-06-24	2013-06-24	440,650	—	$0	0	SEC↗
BLUE bluebird bio, Inc.	J Other deriv	2013-06-24	2013-06-24	23,232	—	$0	23,232	SEC↗
BLUE bluebird bio, Inc.	J Other deriv	2013-06-24	2013-06-24	462,681	—	$0	0	SEC↗
BLUE bluebird bio, Inc.	J Other deriv	2013-06-24	2013-06-24	54,760	—	$0	54,760	SEC↗
BLUE bluebird bio, Inc.	J Other deriv	2013-06-24	2013-06-24	15,152	—	$0	15,152	SEC↗
BLUE bluebird bio, Inc.	C Conversion	2013-06-24	2013-06-24	2,254,357	—	$0	2,254,357	SEC↗
ENTA ENANTA PHARMACEUTICALS INC	C Conversion deriv	2013-03-26	2013-03-28	1,130,000	—	$0	0	SEC↗
ENTA ENANTA PHARMACEUTICALS INC	C Conversion deriv	2013-03-26	2013-03-28	1,017,442	—	$0	0	SEC↗
ENTA ENANTA PHARMACEUTICALS INC	C Conversion deriv	2013-03-26	2013-03-28	500,000	—	$0	0	SEC↗
ENTA ENANTA PHARMACEUTICALS INC	C Conversion deriv	2013-03-26	2013-03-28	563,503	—	$0	0	SEC↗
ENTA ENANTA PHARMACEUTICALS INC	C Conversion deriv	2013-03-26	2013-03-28	3,296,888	—	$0	0	SEC↗
ENTA ENANTA PHARMACEUTICALS INC	C Conversion deriv	2013-03-26	2013-03-28	2,061,246	—	$0	0	SEC↗
ENTA ENANTA PHARMACEUTICALS INC	C Conversion	2013-03-26	2013-03-28	1,006,498	—	$0	1,006,498	SEC↗
ENTA ENANTA PHARMACEUTICALS INC	C Conversion	2013-03-26	2013-03-28	172,030	—	$0	523,044	SEC↗
ENTA ENANTA PHARMACEUTICALS INC	C Conversion	2013-03-26	2013-03-28	155,316	—	$0	391,381	SEC↗
ENTA ENANTA PHARMACEUTICALS INC	P Buy	2013-03-26	2013-03-28	132,949	$14.00	$1.86M	1,617,694	SEC↗
ENTA ENANTA PHARMACEUTICALS INC	C Conversion	2013-03-26	2013-03-28	236,065	—	$0	236,065	SEC↗
ENTA ENANTA PHARMACEUTICALS INC	C Conversion	2013-03-26	2013-03-28	478,247	—	$0	1,484,745	SEC↗
ENTA ENANTA PHARMACEUTICALS INC	C Conversion	2013-03-26	2013-03-28	351,014	—	$0	351,014	SEC↗